HEADER HYDROLASE/HYDROLASE INHIBITOR 27-SEP-18 6MLL TITLE CRYSTAL STRUCTURE OF KPC-2 WITH COMPOUND 7 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC-1; COMPND 5 EC: 3.5.2.6; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 573; SOURCE 4 GENE: BLA, KPC, KPC1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS CARBAPENEMASE, TETRAZOLE, INHIBITOR, COMPLEX, HYDROLASE, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.AKHTAR,Y.CHEN REVDAT 5 13-NOV-24 6MLL 1 REMARK REVDAT 4 11-OCT-23 6MLL 1 REMARK REVDAT 3 18-DEC-19 6MLL 1 REMARK REVDAT 2 26-JUN-19 6MLL 1 JRNL REVDAT 1 17-APR-19 6MLL 0 JRNL AUTH N.J.TORELLI,A.AKHTAR,K.DEFREES,P.JAISHANKAR,O.A.PEMBERTON, JRNL AUTH 2 X.ZHANG,C.JOHNSON,A.R.RENSLO,Y.CHEN JRNL TITL ACTIVE-SITE DRUGGABILITY OF CARBAPENEMASES AND JRNL TITL 2 BROAD-SPECTRUM INHIBITOR DISCOVERY. JRNL REF ACS INFECT DIS. V. 5 1013 2019 JRNL REFN ESSN 2373-8227 JRNL PMID 30942078 JRNL DOI 10.1021/ACSINFECDIS.9B00052 REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3228 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.82 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 21583 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.330 REMARK 3 FREE R VALUE TEST SET COUNT : 2013 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.8307 - 4.4745 1.00 1516 162 0.1898 0.2316 REMARK 3 2 4.4745 - 3.5526 1.00 1436 144 0.1795 0.2217 REMARK 3 3 3.5526 - 3.1038 1.00 1429 149 0.2227 0.2592 REMARK 3 4 3.1038 - 2.8201 1.00 1416 145 0.2577 0.2711 REMARK 3 5 2.8201 - 2.6181 1.00 1392 141 0.2372 0.2985 REMARK 3 6 2.6181 - 2.4638 1.00 1404 143 0.2510 0.3066 REMARK 3 7 2.4638 - 2.3404 1.00 1390 137 0.2389 0.3024 REMARK 3 8 2.3404 - 2.2385 1.00 1395 146 0.2525 0.3097 REMARK 3 9 2.2385 - 2.1524 1.00 1373 143 0.2486 0.3127 REMARK 3 10 2.1524 - 2.0781 1.00 1385 142 0.2493 0.3165 REMARK 3 11 2.0781 - 2.0131 1.00 1374 140 0.2610 0.3346 REMARK 3 12 2.0131 - 1.9556 0.99 1363 144 0.2699 0.3763 REMARK 3 13 1.9556 - 1.9041 0.99 1349 142 0.2817 0.3330 REMARK 3 14 1.9041 - 1.8577 0.97 1348 135 0.3123 0.3694 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6MLL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-SEP-18. REMARK 100 THE DEPOSITION ID IS D_1000236373. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21617 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.11500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.65400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.6.0 REMARK 200 STARTING MODEL: 3C5A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.0 M AMMONIUM SULFATE, 5% (V/V) REMARK 280 ETHANOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.22250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.28150 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.22250 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 37.28150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 430 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 4 REMARK 465 GLY A 5 REMARK 465 SER A 6 REMARK 465 SER A 7 REMARK 465 HIS A 8 REMARK 465 HIS A 9 REMARK 465 HIS A 10 REMARK 465 HIS A 11 REMARK 465 HIS A 12 REMARK 465 HIS A 13 REMARK 465 SER A 14 REMARK 465 SER A 15 REMARK 465 GLY A 16 REMARK 465 LEU A 17 REMARK 465 VAL A 18 REMARK 465 PRO A 19 REMARK 465 ARG A 20 REMARK 465 GLY A 21 REMARK 465 VAL A 292 REMARK 465 ASN A 293 REMARK 465 GLY A 294 REMARK 465 GLN A 295 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 417 O HOH A 417 2555 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -143.99 51.13 REMARK 500 TRP A 105 75.85 54.34 REMARK 500 ARG A 220 -117.03 -118.61 REMARK 500 ASP A 246 137.42 -170.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N1G A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 302 DBREF 6MLL A 25 295 UNP Q9F663 BLKPC_KLEPN 25 293 SEQADV 6MLL MET A 4 UNP Q9F663 INITIATING METHIONINE SEQADV 6MLL GLY A 5 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL SER A 6 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL SER A 7 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL HIS A 8 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL HIS A 9 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL HIS A 10 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL HIS A 11 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL HIS A 12 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL HIS A 13 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL SER A 14 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL SER A 15 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL GLY A 16 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL LEU A 17 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL VAL A 18 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL PRO A 19 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL ARG A 20 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL GLY A 21 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL SER A 22 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL HIS A 23 UNP Q9F663 EXPRESSION TAG SEQADV 6MLL MET A 24 UNP Q9F663 EXPRESSION TAG SEQRES 1 A 290 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 290 LEU VAL PRO ARG GLY SER HIS MET LEU THR ASN LEU VAL SEQRES 3 A 290 ALA GLU PRO PHE ALA LYS LEU GLU GLN ASP PHE GLY GLY SEQRES 4 A 290 SER ILE GLY VAL TYR ALA MET ASP THR GLY SER GLY ALA SEQRES 5 A 290 THR VAL SER TYR ARG ALA GLU GLU ARG PHE PRO LEU CYS SEQRES 6 A 290 SER SER PHE LYS GLY PHE LEU ALA ALA ALA VAL LEU ALA SEQRES 7 A 290 ARG SER GLN GLN GLN ALA GLY LEU LEU ASP THR PRO ILE SEQRES 8 A 290 ARG TYR GLY LYS ASN ALA LEU VAL PRO TRP SER PRO ILE SEQRES 9 A 290 SER GLU LYS TYR LEU THR THR GLY MET THR VAL ALA GLU SEQRES 10 A 290 LEU SER ALA ALA ALA VAL GLN TYR SER ASP ASN ALA ALA SEQRES 11 A 290 ALA ASN LEU LEU LEU LYS GLU LEU GLY GLY PRO ALA GLY SEQRES 12 A 290 LEU THR ALA PHE MET ARG SER ILE GLY ASP THR THR PHE SEQRES 13 A 290 ARG LEU ASP ARG TRP GLU LEU GLU LEU ASN SER ALA ILE SEQRES 14 A 290 PRO GLY ASP ALA ARG ASP THR SER SER PRO ARG ALA VAL SEQRES 15 A 290 THR GLU SER LEU GLN LYS LEU THR LEU GLY SER ALA LEU SEQRES 16 A 290 ALA ALA PRO GLN ARG GLN GLN PHE VAL ASP TRP LEU LYS SEQRES 17 A 290 GLY ASN THR THR GLY ASN HIS ARG ILE ARG ALA ALA VAL SEQRES 18 A 290 PRO ALA ASP TRP ALA VAL GLY ASP LYS THR GLY THR CYS SEQRES 19 A 290 GLY VAL TYR GLY THR ALA ASN ASP TYR ALA VAL VAL TRP SEQRES 20 A 290 PRO THR GLY ARG ALA PRO ILE VAL LEU ALA VAL TYR THR SEQRES 21 A 290 ARG ALA PRO ASN LYS ASP ASP LYS HIS SER GLU ALA VAL SEQRES 22 A 290 ILE ALA ALA ALA ALA ARG LEU ALA LEU GLU GLY LEU GLY SEQRES 23 A 290 VAL ASN GLY GLN HET N1G A 301 25 HET GOL A 302 6 HETNAM N1G 1,5-DIPHENYL-N-(1H-TETRAZOL-5-YL)-1H-PYRAZOLE-3- HETNAM 2 N1G CARBOXAMIDE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 N1G C17 H13 N7 O FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *92(H2 O) HELIX 1 AA1 SER A 22 VAL A 29 1 8 HELIX 2 AA2 VAL A 29 GLY A 41 1 13 HELIX 3 AA3 SER A 71 GLN A 86 1 16 HELIX 4 AA4 GLY A 98 LEU A 102 5 5 HELIX 5 AA5 ILE A 108 TYR A 112 5 5 HELIX 6 AA6 VAL A 119 SER A 130 1 12 HELIX 7 AA7 ASP A 131 LEU A 142 1 12 HELIX 8 AA8 GLY A 144 ILE A 155 1 12 HELIX 9 AA9 LEU A 167 SER A 171 5 5 HELIX 10 AB1 SER A 182 LEU A 195 1 14 HELIX 11 AB2 ALA A 200 GLY A 213 1 14 HELIX 12 AB3 ARG A 220 VAL A 225 5 6 HELIX 13 AB4 GLY A 239 GLY A 242 5 4 HELIX 14 AB5 SER A 275 GLY A 291 1 17 SHEET 1 AA1 5 THR A 56 TYR A 60 0 SHEET 2 AA1 5 SER A 43 ASP A 50 -1 N VAL A 46 O TYR A 60 SHEET 3 AA1 5 ILE A 259 ARG A 266 -1 O TYR A 264 N GLY A 45 SHEET 4 AA1 5 ALA A 244 TRP A 251 -1 N VAL A 250 O ILE A 259 SHEET 5 AA1 5 ALA A 230 THR A 237 -1 N ALA A 230 O TRP A 251 SHEET 1 AA2 2 PHE A 66 PRO A 67 0 SHEET 2 AA2 2 THR A 180 SER A 181 -1 O SER A 181 N PHE A 66 SHEET 1 AA3 2 PRO A 94 ILE A 95 0 SHEET 2 AA3 2 MET A 117 THR A 118 -1 O MET A 117 N ILE A 95 SSBOND 1 CYS A 69 CYS A 238 1555 1555 2.03 CISPEP 1 GLU A 166 LEU A 167 0 4.54 SITE 1 AC1 14 SER A 70 GLN A 85 ALA A 88 PRO A 104 SITE 2 AC1 14 TRP A 105 SER A 130 LEU A 167 ASN A 170 SITE 3 AC1 14 LYS A 234 THR A 235 GLY A 236 THR A 237 SITE 4 AC1 14 CYS A 238 HOH A 452 SITE 1 AC2 4 GLN A 205 LYS A 212 TRP A 251 HOH A 437 CRYST1 57.112 58.445 74.563 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017509 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017110 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013411 0.00000